BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20553527)

  • 1. Epidemiology of recurrent respiratory papillomatosis.
    Larson DA; Derkay CS
    APMIS; 2010 Jun; 118(6-7):450-4. PubMed ID: 20553527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
    Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
    Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
    Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
    Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis].
    Obchinnikov IuM; Kiselev VI; Soldatskiĭ IuL; Artem'ev MI; Onufrieva EK; Baranovskiĭ PM; Shchepin NV; Smetanina SE; Gasparian SF; Steklov AM
    Vestn Otorinolaringol; 2004; (3):29-33. PubMed ID: 15159735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR.
    Draganov P; Todorov S; Todorov I; Karchev T; Kalvatchev Z
    Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):469-73. PubMed ID: 16137771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
    Lacey CJ; Lowndes CM; Shah KV
    Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant degeneration in laryngeal papillomatosis].
    Grøn AL; Schultz JH; Abildgaard J
    Ugeskr Laeger; 2011 Feb; 173(7):506-7. PubMed ID: 21320416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle.
    Armstrong LR; Preston EJ; Reichert M; Phillips DL; Nisenbaum R; Todd NW; Jacobs IN; Inglis AF; Manning SC; Reeves WC
    Clin Infect Dis; 2000 Jul; 31(1):107-9. PubMed ID: 10913405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts on human papillomavirus infections in children.
    Syrjänen S
    APMIS; 2010 Jun; 118(6-7):494-509. PubMed ID: 20553530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children.
    Donne AJ; Clarke R
    Int J STD AIDS; 2010 Jun; 21(6):381-5. PubMed ID: 20606216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
    Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
    Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer.
    Reidy PM; Dedo HH; Rabah R; Field JB; Mathog RH; Gregoire L; Lancaster WD
    Laryngoscope; 2004 Nov; 114(11):1906-9. PubMed ID: 15510012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
    Novakovic D; Cheng AT; Cope DH; Brotherton JM
    Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent respiratory papillomatosis.
    Kashima HK; Mounts P; Shah K
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):699-706. PubMed ID: 8869953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
    Go C; Schwartz MR; Donovan DT
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP).
    Shehata BM; Otto KJ; Sobol SE; Stockwell CA; Foulks C; Lancaster W; Gregoire L; Hill CE
    Pediatr Dev Pathol; 2008; 11(2):118-21. PubMed ID: 17990904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of malignant transformation of laryngeal papilloma in Taiwan.
    Lee LA; Cheng AJ; Fang TJ; Huang CG; Liao CT; Chang JT; Li HY
    Laryngoscope; 2008 Jan; 118(1):50-5. PubMed ID: 17975511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent respiratory papillomatosis: update 2008.
    Gallagher TQ; Derkay CS
    Curr Opin Otolaryngol Head Neck Surg; 2008 Dec; 16(6):536-42. PubMed ID: 19005325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination.
    Chesson HW; Forhan SE; Gottlieb SL; Markowitz LE
    Vaccine; 2008 Aug; 26(35):4513-8. PubMed ID: 18598734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.